Cue Biopharma, Inc. Liquidation Value
CUE
Other
Cash & Equivalents
$27.14M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $27.14M
Total Obligations: -$17.69M
$9.45M
Per share: $0.10
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $27.14M
AR: $5.55M
Total Obligations: -$17.69M
$14.99M
Per share: $0.16
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $27.14M
AR: $5.55M
Inventory: $0
Total Obligations: -$17.69M
$14.99M
Per share: $0.16
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $9.45M | $0.10 |
| Liquid Liquidation Value | $14.99M | $0.16 |
| Operating Liquidation Value | $14.99M | $0.16 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $27.14M |
| Accounts Receivable | $5.55M |
| Inventory | N/A |
| Current Liabilities | $13.49M |
| Long-term Debt | $0 |
| Op. Lease Liability | $4.20M |
| Finance Lease | N/A |
| Shares Outstanding | 96.6M |
Explore all 141 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $27.14M | $5.55M | N/A | $3.95M | $13.49M | N/A | $4.20M | N/A |
| 2025-09-30 | $11.70M | $387,000 | N/A | $2.35M | $15.52M | N/A | $4.71M | N/A |
| 2025-06-30 | $27.49M | $532,000 | N/A | $3.63M | $19.25M | N/A | $5.22M | N/A |
| 2025-03-31 | $13.14M | $0 | N/A | $3.78M | $15.50M | N/A | $3.75M | N/A |
| 2024-12-31 | $22.46M | $945,000 | N/A | $2.82M | $13.69M | $0 | $4.54M | N/A |
| 2024-09-30 | $32.42M | $3.15M | N/A | $6.47M | $16.79M | $1.00M | $4.22M | N/A |
| 2024-06-30 | $30.03M | $1.85M | N/A | $3.91M | $16.46M | $2.00M | $5.01M | N/A |
| 2024-03-31 | $41.03M | $1.40M | N/A | $3.92M | $18.09M | $3.00M | $5.79M | N/A |
▼ Community Notes